ArticlePathology oncology research : POR2015

Determination of HER2 and p53 Mutations by Sequence Analysis Method and EGFR/Chromosome 7 Gene Status by Fluorescence in Situ Hybridization for the Predilection of Targeted Therapy Modalities in Immunohistochemically Triple Negative Breast Carcinomas in Turkish Population.

Emel Ebru Pala et al.PubMed ↗Publisher ↗

No numbers read from the abstract.